Home > European web survey on drugs 2021: Irish results.

Mongan, Deirdre ORCID: https://orcid.org/0000-0003-3616-4253, Killeen, Nicki ORCID: https://orcid.org/0000-0001-6220-1586, Evans, David, Millar, Seán ORCID: https://orcid.org/0000-0003-4453-8446, Keenan, Eamon ORCID: https://orcid.org/0000-0002-3395-3831 and Galvin, Brian ORCID: https://orcid.org/0000-0002-5639-1819 (2022) European web survey on drugs 2021: Irish results. Dublin: Health Research Board.

PDF (European web survey on drugs 2021: Irish results) - Published Version

Ireland participated in the European Web survey on drugs (EWSD) for the first time in 2021 with the aim of capturing those who use drugs but may not experience dependency issues, as well as niche user groups such as those consuming psychedelic-type drugs. This report presents Ireland’s main findings from the 2021 EWSD.

The data collected provide information on:
• The frequency of drug use by drug type, and the amount consumed on a typical day
• Drug use patterns according to sex and age
• The reasons why people use drugs, by drug type
• The main sources used to obtain drugs, and
• The impact of the COVID-19 pandemic on drug use.

Item Type
Publication Type
Irish-related, Report
Drug Type
Substances (not alcohol/tobacco), Cannabis, CNS depressants / Sedatives, CNS stimulants, Cocaine, New psychoactive substance
Intervention Type
Screening / Assessment
4 August 2022
Call No
HRB publications
76 p.
Health Research Board
Place of Publication
ISBN: 9781903669280
When interpreting the results presented in this report, it is important to consider them in the context of the survey’s strengths and limitations. The Irish EWSD had a very comprehensive and effective recruitment campaign, which utilised many different online channels and achieved a large response, with 5,796 people who had used drugs in the last year completing the survey. This ensured that we had sufficient numbers to adequately analyse patterns of drug use, which has not been feasible in Ireland to date. Online surveys cannot provide population drug use prevalence data; therefore, the results presented here are not generalisable to the general population.
Accession Number
HRB 5425 (Available), HRB 5426 (Available)
Related (external) link

Repository Staff Only: item control page